JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Reg. 34 (1) Annual Report.
Notice of Annual General Meeting and Annual Report for the financial year ended 31st March, 202223-08-2022
23-08-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Annual General Meeting ('AGM') Will Be Held On Wednesday, September 14, 2022 At 03:30 P.M. (IST) Through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM").
Intimation for Notice of Annual General Meeting to be held through Video Conferencing or Other Audio-Visual Means and Record Date for remote E- voting.23-08-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on the financial results for the quarter ended 30.06.2022.09-08-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Financial Results For The Quarter Ended 30.06.2022
Financial results for the quarter ended 30.06.2022 along with the press release and result presentation.09-08-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Board Meeting Outcome for OUTCOME OF THE MEETING OF BOARD OF DIRECTORS OF JAGSONPAL PHARMACEUTICALS LIMITED HELD ON AUGUST 09TH, 2022.
Please find attached the Unaudited Financial Results (Standalone) of the Company along with Limited Review Report of the Statutory Auditors for the quarter ended June 30, 2022, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard.09-08-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 30Th June, 2022
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2022 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter ended 30th June, 2022. Accordingly, trading window for designated persons of the Company was closed on July 1, 2022 and will remain closed until August 11, 2022.04-08-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 30th June, 2022.20-07-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (SEBI LODR)
Authorization for determining materiality of an event or information under the SEBI LODR.16-07-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for appointment of Mr. Manish Gupta as the Managing Director of the Company.16-07-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Appointment of Statutory Auditors.16-07-2022